Pharma

From 2000 to 2017, the number of registered clinical trials featuring CGMs, apps and other connected devices rose at a 34% CAGR, according to new data from Harvard researchers.

The advantages to health and human service delivery in a bot workforce include speed, reliability, consistency and cost-effectiveness. Sound too far-fetched for your management team? We would disagree.  

The test was designed to identify specific antibodies in order to detect if a patient has had coronavirus in the past. 

The startup is working with national emergency services to remotely triage, support and manage infected people in isolation.

German-based Ralf Jahns, MD at Research2Guidance, explains the role of different stakeholders in fighting COVID-19.

The HIMSS Media team gives a recap of recent headlines surrounding the FDA, COVID-19 and new digital health software products.

Also: Providence supporting COVID-19 patients at home with Xealth and Twistle; Lief Therapeutics incorporates DrChrono's Open API.

Dr. Yuri Maricich, chief medical officer at Pear Therapeutics, speaks on his company's experience bringing a digital therapeutic product through the regulator's experimental program for health software.

Somryst, a prescription digital therapeutic combining cognitive behavioral therapy and personalized sleep restriction, is the first software product to put the FDA's early Precertification Program framework through its paces. 

Chairman of the UAE’s IBC Group is working with the UK biotech research company, Vaxbio to launch an affordable vaccine that the company hopes to launch by the summer.